During the current opioid crisis, only one-third of youths diagnosed with opioid use disorder were tested for hepatitis C, according to the results of a large national sample presented at IDWeek.
A study in 20 patients has demonstrated that transplantation followed by antiviral therapy has been successful in patients receiving kidneys from hepatitis C-infected donors.
Take a look at how portable, long-read nanopore sequencing can be applied to the study of hepatitis B virus.
Take a look behind the scenes of a recent Future Virology review as we ask author Geoffrey Dusheiko about the challenges facing hepatitis B and what the future may hold in terms of functional cure and new research directions.
In our latest infographic we provide a visual snapshot of the infections and immune processes that have been linked with the microbiome thus far, explaining some of the evidence
We take a look back at some of the largest outbreaks of 2017 and their impacts. Read the full story to learn more.
Researchers have established a map of protein interactions for the replication machinery of chronic viruses, shedding insight into viral strategies and uncovering potential drug targets.
With decreasing global boundaries and subsequently increasing travel, we’ve taken a look at five of the most common infectious diseases posing a risk to travelers in our latest infographic.
Researchers have discovered sequence-specific interactions between hepatitis B proteins and pre-genome RNA that may play a crucial role in nucleocapsid assembly. This could be targeted in future drug development.
Viral hepatitis is a leading cause of mortality and morbidity worldwide, and in May we looked closer at this disease in line with Hepatitis Awareness Month.
